Change in hearing and tinnitus in conservatively managed vestibular schwannomas
- PMID: 18174921
- PMCID: PMC2039713
- DOI: 10.1055/s-2007-984491
Change in hearing and tinnitus in conservatively managed vestibular schwannomas
Abstract
Objectives: The aim of this study was to evaluate the change of hearing and tinnitus in a group of conservatively managed unilateral vestibular schwannomas (VS).
Design: Retrospective case series review.
Setting: Tertiary referral otoneurological and skull base surgery department.
Participants: Seventy patients affected by unilateral VS with at least two audiograms available were retrospectively evaluated.
Main outcome measures: Changes in pure tone average (PTA), speech discrimination score (SDS), and tinnitus were analyzed.
Results: At diagnosis 16 patients (22.9%) had a PTA of 0 to 30 dB and 38 (54.4%) a PTA of 0 to 50 dB. At the end of the follow-up period, 9 patients (12.9%) had a PTA of 0 to 30 dB and 27 (38.7%) had a PTA of 0 to 50 dB, representing a hearing preservation rate of 56% and 70%, respectively. Of patients with both tonal and speech audiometry, 71.4% with class A hearing (PTA < 30 dB/SDS > 70%) maintained their initial hearing and 60% with class A or B hearing (PTA < 50 dB/SDS > 50%) maintained this useful hearing. Forty-two patients (60%) did not show a significant growth in their tumor over the period of observation. In this group of patients the mean PTA after a mean follow-up time of 40 months decreased from 44 dB HL to 50.8 dB HL, with a yearly rate of 2.47 dB HL. The chance of maintaining a PTA of 0 to 30 dB in this group of patients was 57.1% and a PTA of 0 to 50 dB was 81.4%.
Conclusions: In this group of patients affected by VS and managed conservatively with a mean follow-up of 33.3 months, the risk of losing eligibility for hearing preservation surgery was lower than 30%.
Keywords: Vestibular schwannoma; conservative management; hearing preservation.
Figures
References
-
- Tschudi D C, Linder T E, Fisch U. Conservative management of unilateral acoustic neuromas. Am J Otol. 2000;21:722–728. - PubMed
-
- Hoistad D L, Melnik G, Mamikoglu B, Battista R, O'Connor C A, Wiet R J. Update on conservative management of acoustic neuroma. Otol Neurotol. 2001;22:682–685. - PubMed
-
- Fucci M J, Buchman C A, Brackmann D E, Berkliner K I. Acoustic tumor growth:implications for treatment choices. Am J Otol. 1999;20:495–499. - PubMed
-
- Charabi S, Tos M, Thomsen J, Charabi B, Mantoni M. Vestibular schwannoma growth: the continuing controversy. Laryngoscope. 2000;110:1720–1725. - PubMed
-
- Warrick P, Bance M, Rutka J. The risk of hearing loss in nongrowing, conservatively managed acoustic neuromas. Am J Otol. 1999;20:758–762. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
